Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Basic research on nedocromil sodium].

M Joseph1, D K Rainey

  • 1CNRS (CJF INSERM 90-06), Institut Pasteur de Lille, France.

Revue Des Maladies Respiratoires
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The extent of carbapenem-resistant encoding genes in Klebsiella pneumoniae from COVID-19 and non-COVID-19 patients in a tertiary care center, Saudi Arabia.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2025
Same author

The microbial 'link' that matters.

British dental journal·2024
Same author

Voice-activated charting systems.

British dental journal·2024
Same author

[Clinical, diagnostic and evolutionary profile of peritoneal tuberculosis at the national reference general hospital of Ndjamena about 69 cases].

Le Mali medical·2024
Same author

Cloud intelligence in diagnosis?

British dental journal·2023
Same author

NHS dentists and pension sustainability.

British dental journal·2023
Same journal

[French version of the guidelines for connective tissue disease-associated ILD].

Revue des maladies respiratoires·2026
Same journal

[Pulmonary expression of an asymptomatic lysosomal storage disorder].

Revue des maladies respiratoires·2026
Same journal

[Factors associated with FEV1 evolution in cystic fibrosis patients treated by CFTR modulator tritherapy].

Revue des maladies respiratoires·2026
Same journal

[Subacute pulmonary coccidioidomycosis: A differential diagnosis of lung cancer].

Revue des maladies respiratoires·2026
Same journal

[Relevance of the ACT score in severe asthma with obesity: A pilot study].

Revue des maladies respiratoires·2026
Same journal

[Automated analysis of mandibular movements for the screening of obstructive sleep apnea].

Revue des maladies respiratoires·2026
See all related articles

Nedocromil sodium effectively inhibits allergic reactions by targeting key inflammatory cells and mediators. This novel compound shows promise in treating airway diseases by blocking bronchoconstriction and reducing inflammation.

Area of Science:

  • Pharmacology
  • Immunology
  • Respiratory Medicine

Context:

  • Nedocromil sodium is a novel chemical entity distinct from existing airway disease treatments.
  • Its hydrophilic nature facilitates absorption in lung tissue but limits absorption in the gastrointestinal tract.
  • The compound's unique chemical structure differentiates it from current therapeutic agents.

Purpose:

  • To review the in vitro and in vivo effects of nedocromil sodium.
  • To elucidate the mechanisms by which nedocromil sodium modulates allergic and inflammatory responses.
  • To assess its potential as a therapeutic agent for airway diseases.

Summary:

  • Nedocromil sodium inhibits neutrophil chemotaxis, IgE-mediated activation of macrophages and monocytes, histamine release from mast cells, platelet cytotoxicity, and LTC4 release from eosinophils.

Related Experiment Videos

  • In animal models, it blocks antigen-induced immediate bronchoconstriction, adenosine, and neurokinin A.
  • It also attenuates antigen-induced increases in bronchial responsiveness and reduces ovalbumin-induced vascular permeability.

    • Impact:

    • Nedocromil sodium demonstrates significant anti-inflammatory effects in both in vitro and in vivo models.
    • It targets multiple cellular components involved in allergic reactions, suggesting broad therapeutic potential.
    • The findings support nedocromil sodium's potential as a new treatment for inflammatory airway diseases.